{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:45:15Z","timestamp":1792507515374,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.autrev.2022.103167","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T12:35:35Z","timestamp":1659443735000},"page":"103167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)"],"prefix":"10.1016","volume":"21","author":[{"given":"Cristina","family":"Carbonell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Guill\u00e9n-del-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rubio-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Argibay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Mar\u00edn-Ballv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Rodr\u00edguez-Pint\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bald\u00e0-Masmiquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Callejas-Moraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Colunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"S\u00e1ez-Comet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gonz\u00e1lez-Ech\u00e1varri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Ortego-Centeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Mar\u00ed-Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Antonio","family":"Vargas-Hitos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Antonio","family":"Todol\u00ed-Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Trapiella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Teresa","family":"Herranz-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayka","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Castro-Salom\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Perales-Fraile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Bel\u00e9n","family":"Madro\u00f1ero-Vuelta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Esther","family":"S\u00e1nchez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ruiz-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"S\u00e1nchez-Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"de-la-Red-Bellvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Fern\u00e1ndez-Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Muela-Molinero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema-Mar\u00eda","family":"Lled\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Tolosa-Vilella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicent","family":"Fonollosa-Pla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio-Javier","family":"Chamorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen-Pilar","family":"Sime\u00f3n-Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103167_bb0005","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2022.103167_bb0010","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2022.103167_bb0015","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103167_bb0020","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR scleroderma trials and research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103167_bb0025","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001728","article-title":"Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death","volume":"94","author":"Sime\u00f3n-Aznar","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103167_bb0030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103167_bb0035","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103167_bb0040","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/art.37969","article-title":"Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies: cancer incidence in SSc","volume":"65","author":"Onishi","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103167_bb0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/kes303","article-title":"Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies","volume":"52","author":"Bonifazi","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103167_bb0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.canep.2013.04.014","article-title":"The risk of cancer development in systemic sclerosis: a meta-analysis","volume":"37","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.autrev.2022.103167_bb0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.14740\/jocmr2606w","article-title":"Systemic sclerosis and malignancy: a review of current data","volume":"8","author":"Zeineddine","year":"2016","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.autrev.2022.103167_bb0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5301\/jsrd.5000250","article-title":"Mechanistic and clinical insights at the scleroderma-cancer interface","volume":"2","author":"Shah","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.autrev.2022.103167_bb0065","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar4486","article-title":"Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma","volume":"16","author":"Moinzadeh","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2022.103167_bb0070","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/1346-8138.12827","article-title":"Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis","volume":"42","author":"Saigusa","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2022.103167_bb0075","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/art.39022","article-title":"Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma: age in scleroderma and cancer","volume":"67","author":"Shah","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103167_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-212999","article-title":"Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer","author":"Igusa","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103167_bb0085","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.autrev.2012.06.003","article-title":"Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature","volume":"12","author":"Colaci","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103167_bb0090","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/art.1780350621","article-title":"Association of anti-topoisomerase I with cancer","volume":"35","author":"Rothfield","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103167_bb0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","article-title":"Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers","volume":"24","author":"Barnes","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl. 106","key":"10.1016\/j.autrev.2022.103167_bb0100","first-page":"89","article-title":"Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review","volume":"35","author":"Freire","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2022.103167_bb0105","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103167_bb0110","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103167_bb0115","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103167_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2022.103167_bb0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.semarthrit.2016.04.007","article-title":"Digital ulcers and cutaneous subsets of systemic sclerosis: clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry","volume":"46","author":"Tolosa-Vilella","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103167_bb0130","series-title":"Cancer today [Internet]","article-title":"Global cancer observatory (GCO)","author":"International Agency for Research on Cancer (IARC)","year":"2018"},{"key":"10.1016\/j.autrev.2022.103167_bb0135","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/art.1780281204","article-title":"Cancer and systemic sclerosis. An epidemiologic study","volume":"28","author":"Roumm","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103167_bb0140","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2133.2010.09861.x","article-title":"Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study: systemic sclerosis and the risk of cancer","volume":"163","author":"Olesen","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103167_bb0145","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ard.62.8.728","article-title":"Risk of cancer in patients with scleroderma: a population based cohort study","volume":"62","author":"Hill","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103167_bb0150","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2169\/internalmedicine.51.7686","article-title":"Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis","volume":"51","author":"Hashimoto","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2022.103167_bb0155","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/art.21225","article-title":"Risk of malignancy in scleroderma: a population-based cohort study","volume":"52","author":"Chatterjee","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103167_bb0160","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/art.1780360405","article-title":"Cancer in systemic sclerosis","volume":"36","author":"Abu-Shakra","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103167_bb0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/03009740802642062","article-title":"Incidence of cancer among patients with systemic sclerosis in Korea: results from a single Centre","volume":"38","author":"Kang","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103167_bb0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/03009742.2011.618145","article-title":"Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan","volume":"41","author":"Kuo","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103167_bb0175","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.autrev.2017.03.012","article-title":"Novel risk factors related to cancer in scleroderma","volume":"16","author":"Bernal-Bello","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103167_bb0180","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3390\/jcm9030853","article-title":"Biphasic temporal relationship between cancers and systemic sclerosis: a clinical Series from Montpellier University Hospital and review of the literature","volume":"9","author":"Partouche","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2022.103167_bb0185","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/1756-185X.13311","article-title":"Systemic sclerosis and malignancy","volume":"21","author":"Sargin","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103167_bb0190","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.revmed.2019.06.004","article-title":"Survenue de cancers au cours de la scl\u00e9rodermie syst\u00e9mique: facteurs de risque, impact sur la survie et revue de la litt\u00e9rature","volume":"40","author":"Catano","year":"2019","journal-title":"Rev M\u00e9decine Interne"},{"key":"10.1016\/j.autrev.2022.103167_bb0195","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/acr.24076","article-title":"Incidence, risk factors, and outcomes of cancer in systemic sclerosis","volume":"72","author":"Morrisroe","year":"2020","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2022.103167_bb0200","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-016-3288-8","article-title":"Risk factors for malignancy in systemic sclerosis patients","volume":"35","author":"Ka\u015fifo\u011flu","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103167_bb0205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00296-009-1348-y","article-title":"Malignancy in scleroderma patients from south West England: a population-based cohort study","volume":"31","author":"Siau","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2022.103167_bb0210","first-page":"1113","article-title":"A cohort study of cancer incidence in systemic sclerosis","volume":"33","author":"Derk","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103167_bb0215","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archderm.1979.04010080014013","article-title":"Cancer and scleroderma","volume":"115","author":"Duncan","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2022.103167_bb0220","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/1097-0142(19950901)76:5<910::AID-CNCR2820760528>3.0.CO;2-T","article-title":"Incidence of cancer among patients with systemic sclerosis","volume":"76","author":"Rosenthal","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.autrev.2022.103167_bb0225","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0306-9877(98)90263-8","article-title":"Primary biliary cirrhosis in patients with breast cancer: studying the link","volume":"50","author":"Bergasa","year":"1998","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.autrev.2022.103167_bb0230","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.semarthrit.2017.10.004","article-title":"Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: characteristics and survival of patients from the Spanish RESCLE registry","volume":"47","author":"Mar\u00ed-Alfonso","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103167_bb0235","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2022.103167_bb0240","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s100670050029","article-title":"Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis","volume":"19","author":"Higuchi","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103167_bb0245","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.3899\/jrheum.100402","article-title":"Anticentromere-a and Anticentromere-B antibodies show high concordance and similar clinical associations in patients with systemic sclerosis","volume":"37","author":"Hanke","year":"2010","journal-title":"J Rheumatol"},{"issue":"Suppl. 106","key":"10.1016\/j.autrev.2022.103167_bb0250","first-page":"98","article-title":"Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis","volume":"35","author":"Iniesta Arandia","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2022.103167_bb0255","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-019-1867-1","article-title":"Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature","volume":"21","author":"Pokeerbux","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2022.103167_bb0260","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.3389\/fimmu.2018.03112","article-title":"Intriguing relationships between cancer and systemic sclerosis: role of the immune system and other contributors","volume":"9","author":"Maria","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103167_bb0265","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.40893","article-title":"Protective effect against cancer of antibodies to the large subunits of both RNA polymerases I and III in scleroderma","volume":"71","author":"Shah","year":"2019","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103167_bb0270","doi-asserted-by":"crossref","first-page":"E7526","DOI":"10.1073\/pnas.1615990113","article-title":"Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer","volume":"113","author":"Xu","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2022.103167_bb0275","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.autrev.2014.03.003","article-title":"Systemic sclerosis, breast cancer and calcium channel blockers: a new player on the scene?","volume":"13","author":"Bernal-Bello","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103167_bb0280","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ijc.32083","article-title":"Long-term use of low-dose aspirin for cancer prevention: a 10-year population cohort study in Hong Kong","volume":"145","author":"Tsoi","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.autrev.2022.103167_bb0285","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2016.05.083","article-title":"Aspirin and cancer","volume":"68","author":"Patrignani","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2022.103167_bb0290","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1538-7836.2011.04194.x","article-title":"Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation: thromboxane-dependent release of platelet S1P","volume":"9","author":"Ulrych","year":"2011","journal-title":"J Thromb Haemost"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:26:22Z","timestamp":1761600382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222001379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1568997222001379"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103167","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103167"}}